EU
RYTM icon

Emory University’s Rhythm Pharmaceuticals RYTM Stock Holding History

Emory University’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-71,856
Closed -$1.55M – 10
2019
Q3 		$1.55M Sell
71,856
-14,352
-17% -$308K 3.06% 5
2019
Q2 		$1.9M Buy
86,208
+6,810
+9% +$172K 1.34% 36
2019
Q1 		$2.18M Sell
79,398
-3,369
-4% -$96.8K 1.53% 28
2018
Q4 		$2.23M Buy
+82,767
New +$2.29M 1.75% 14

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Emory University's RYTM Position: Q4 2019 in Review

Emory University sold out of Rhythm Pharmaceuticals (RYTM) in Q4 2019, closing a stake of 71,856 shares — an estimated $1.55M sold.

Emory University first reported a position in RYTM in Q4 2018 and held it in 4 quarters. The position peaked at $2.23M in Q4 2018. 89 funds tracked by Wall St. Rank hold RYTM as of Q4 2019.

  • Emory University reported no remaining Rhythm Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Emory University sold 71,856 Rhythm Pharmaceuticals shares in Q4 2019, an estimated $1.55M.
  • Emory University first reported a position in Rhythm Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Emory University's Rhythm Pharmaceuticals position peaked at $2.23M in Q4 2018.
  • 89 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2019.

Based on Emory University's 13F filing for Q4 2019, filed 13 Feb 2020.